Amazon Web Services (AWS) is a strategic Technology Alliance partner of DNAnexus, and together we provide our joint customers with the ability to accelerate their research, foster collaboration and provide better outcomes.
.svg.webp?width=258&height=55&name=Microsoft_logo_(2012).svg.webp){kind=logo}
Microsoft and DNAnexus empower organizations to re-envision the way they bring together people, data, and processes that better engage patients and optimize clinical and operational effectiveness.
We have teamed up with Oracle to advance precision health by connecting our respective ecosystems, including making the DNAnexus platform seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers.
Intelliseq and DNAnexus have partnered to simplify and accelerate variant interpretation and clinical reporting. The integrated, one-click solution streamlines NGS data analysis and provides scientists with the ability to generate critical insights into somatic cancers, hereditary diseases, and other precision medicine and biomedical research applications.
Fabric Genomics and DNAnexus have partnered to provide a push-button solution to interpret genomic sequences, detect clinically meaningful variants, and generate comprehensive patient reports. The workflow helps reduce overall analysis costs and significantly improves turnaround times from days to hours for a range of clinical rare genetic disorders and oncology diagnostics.
NVIDIA partners with DNAnexus to accelerate time to value for scientific research. DNAnexus makes it easy to run NVIDIA Parabricks pipelines by providing an out-of-the-box solution.
BigOmics’ collaborative analysis environment, Omics Playground, is now available on the DNAnexus precision health data platform, providing customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.
Utilizing Sentieon’s tools on DNAnexus, clinicians and researchers can perform accurate and cost-effective analysis of petabyte-scale datasets with ease, seamlessly running analyses of an arbitrary number of samples simultaneously in the cloud.
Lorenz Life Sciences and DNAnexus have partnered to offer Trusted Regulatory Spaces — secure, cloud-native environments that improve the submission validation process and ease of sponsor-reviewer communication for human drug and biologics applications to health authorities.
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms.
Cognizant engineers modern businesses, helping their clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world.
Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale.
Ovation is a clinicogenomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine.
TMA Precision Health and DNAnexus have partnered to advance basic and translational research for patients who have a rare disease. As part of the collaboration, qualified researchers will be able to use the DNAnexus Precision Health Data Cloud and analysis tools to access and explore TMA’s high-quality whole genome sequencing data and associated longitudinal medical records.
The UK Biobank Research Analysis Platform (RAP), enabled by DNAnexus, exponentially increases the scale and accessibility of the world’s largest and most comprehensive biomedical database for researchers around the world to advance understanding of human disease.
Our Future Health, powered by DNAnexus, is a collaboration between the public, private and charity sectors. It aims to be the UK’s largest health research programme, bringing people together to develop new ways to prevent, detect and treat disease.
PacBio is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems.
Element Biosciences is developing disruptive DNA sequencing and other omics technology for research and diagnostic markets. DNAnexus and Element Biosciences have partnered to allow customers to stream data from Element's AVITI™ System directly to their DNAnexus account. The collaboration combines the unmatched performance of AVITI sequencing with the secure and full-featured multi-omic analysis platform of DNAnexus.
